Safety and Efficacy of Endovenous Ablation in Patients with a History of Deep Venous Thrombosis.

Deep venous thrombosis Endovenous ablation Superficial venous insufficiency Vascular Quality Initiative Venous thromboembolism

Journal

Journal of vascular surgery. Venous and lymphatic disorders
ISSN: 2213-3348
Titre abrégé: J Vasc Surg Venous Lymphat Disord
Pays: United States
ID NLM: 101607771

Informations de publication

Date de publication:
25 Apr 2024
Historique:
received: 29 02 2024
revised: 08 04 2024
accepted: 11 04 2024
medline: 28 4 2024
pubmed: 28 4 2024
entrez: 27 4 2024
Statut: aheadofprint

Résumé

Endovenous ablation is the standard of care for patients with symptomatic superficial venous insufficiency. For patients with a history of deep venous thrombosis (DVT), there is concern for an increased risk of post-procedural complications, particularly venous thromboembolism (VTE). The objective of this study was to evaluate the safety and efficacy of endovenous thermal ablation in patients with a history of DVT. The national Vascular Quality Initiative (VQI) Varicose Vein Registry (VVR) was queried for superficial venous procedures performed from January 2014-July 2021. Limbs treated with radiofrequency or laser ablation were compared between patients with and without a DVT history. The primary safety endpoint was incident DVT or endothermal heat-induced thrombosis (EHIT) II-IV in the treated limb at <3-month follow-up. Secondary safety endpoints included any proximal thrombus extension (i.e., EHIT I-IV), major bleeding, hematoma, pulmonary embolism (PE), and death due to the procedure. The primary efficacy endpoint was technical failure (i.e., recanalization at <1-week follow-up). Secondary efficacy endpoints included the risk of recanalization over time and the post-procedural change in quality-of-life measures. Outcomes by pre-operative use of anticoagulation (AC) were also compared among those with prior DVT. Among 33,892 endovenous thermal ablations performed on 23,572 individual patients aged 13-90, 1,698 patients (7.2%) had a history of DVT. Patients with prior DVT were older (p<0.001), of higher BMI (p<0.001), more likely to be male at birth (p<0.001) and black/African American (p<0.001), and had greater CEAP classifications (p<0.001). A history of DVT conferred higher risk of new DVT (1.4% vs. 0.8%, p=0.03), proximal thrombus extension (2.3% vs. 1.6%, p=0.045), and bleeding (0.2% vs. 0.04%, p=0.03). EHIT II-IV, PE, and hematoma risk did not differ by DVT history (p=NS). No deaths from treatment occurred in either group. Continuing pre-operative AC in patients with prior DVT did not change the risk of any complications after endovenous ablation (p=NS) but did confer increased hematoma risk among all endovenous thermal ablations and surgeries (p=0.001). Technical failure was similar between groups (2.0% vs. 1.2%, p=0.07), though a history of DVT conferred increased recanalization risk over time (HR=1.90, 95% CI [1.46, 2.46]), p<0.001). Groups had comparable improvement in post-procedural VCSS/HASTI scores (p=NS). Endovenous thermal ablation in patients with a history of DVT was effective. However, appropriate patient counseling regarding a heightened DVT risk, albeit still low, is critical. The decision to continue or withhold AC pre-operatively should be tailored on a case-by-case basis.

Identifiants

pubmed: 38677553
pii: S2213-333X(24)00216-6
doi: 10.1016/j.jvsv.2024.101898
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

101898

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Auteurs

Ethan Chervonski (E)

New York University Grossman School of Medicine, New York, NY.

Furqan Muqri (F)

Division of Vascular and Endovascular Surgery, Department of Surgery, New York University Langone Health, New York, NY.

Glenn R Jacobowitz (GR)

Division of Vascular and Endovascular Surgery, Department of Surgery, New York University Langone Health, New York, NY.

Caron B Rockman (CB)

Division of Vascular and Endovascular Surgery, Department of Surgery, New York University Langone Health, New York, NY.

Thomas S Maldonado (TS)

Division of Vascular and Endovascular Surgery, Department of Surgery, New York University Langone Health, New York, NY.

Todd L Berland (TL)

Division of Vascular and Endovascular Surgery, Department of Surgery, New York University Langone Health, New York, NY.

Karan Garg (K)

Division of Vascular and Endovascular Surgery, Department of Surgery, New York University Langone Health, New York, NY.

Neal S Cayne (NS)

Division of Vascular and Endovascular Surgery, Department of Surgery, New York University Langone Health, New York, NY.

Mikel Sadek (M)

Division of Vascular and Endovascular Surgery, Department of Surgery, New York University Langone Health, New York, NY. Electronic address: mikel.sadek@nyulangone.org.

Classifications MeSH